Love Island Star Breaks Silence on Family's DES Drug Ordeal
In a groundbreaking revelation, former Love Island contestant Maxwell Samuda has become the first man to publicly attribute serious health problems to a controversial pregnancy drug taken by his grandmother decades ago. The 26-year-old reality television personality believes his reproductive system issues directly result from exposure to diethylstilbestrol (DES), a synthetic hormone prescribed to approximately 300,000 British women between the 1940s and 1970s.
A Multigenerational Health Crisis
Maxwell Samuda's family represents a tragic case study of DES's devastating legacy across generations. His grandmother, Maureen Day from Herne Bay in Kent, took the drug during her second pregnancy in 1972-1973 to prevent miscarriage and later to suppress breast milk production after her premature son passed away. Now 78, Mrs. Day was diagnosed with breast cancer four years ago and firmly believes DES caused her illness.
The drug's impact extended to Maxwell's mother, Natalie Samuda, 50, who underwent multiple medical procedures including removal of pre-cancerous cervical cells at age 25, fallopian tube removal due to fluid accumulation, and a complete hysterectomy last year. She also suffers from multiple autoimmune conditions that have significantly affected her daily life for nearly a decade.
Maxwell's Personal Health Battle
Despite maintaining a healthy lifestyle that includes regular exercise and abstaining from smoking and drinking, Maxwell Samuda faces significant reproductive challenges. As an infant, he required surgery for undescended testes. Five years ago, he discovered a benign lump on his scrotum and was diagnosed with varicocele, a condition involving enlarged veins. Most concerningly, a semen analysis revealed he has a low sperm count, potentially jeopardizing his dream of starting a family.
"Having a family is something that I'm really keen on doing one day," Maxwell revealed. "Being told that you might potentially have issues with that - something I've always taken for granted in my head - I all of a sudden thought, 'oh, I'm not actually guaranteed that'... it's definitely an unsettling feeling."
The DES Drug: A Historical Medical Scandal
Diethylstilbestrol was originally marketed as a wonder drug to prevent miscarriage, suppress breast milk production, and treat menopause symptoms. However, in 1971, American regulators discovered its link to clear cell adenocarcinoma, a rare cancer of the cervix and vagina, and advised against prescribing it to pregnant women. Despite this warning, DES continued to be prescribed in Europe until the late 1970s.
According to campaign group DES Justice UK (DJUK), the drug has caused widespread infertility, reproductive abnormalities, and increased cancer risks. Beyond the initially identified cervical and vaginal cancers, DES has been linked to breast, pancreatic, and other cancers. The organization describes the situation as a "silent scandal" that continues to affect lives today.
Campaigning for Justice and Awareness
The Samuda family has joined DJUK's campaign demanding a full public inquiry into the DES scandal and the establishment of a compensation scheme for affected families. Unlike the United States and the Netherlands, which have implemented compensation programs for DES victims, the United Kingdom has yet to take similar action.
Natalie Samuda, a former midwife, emphasized the need for accountability: "Coming from a healthcare background myself, it needs a full inquiry to understand how, what, why and when, to ensure that this can't happen again. So many people's lives have been affected."
DJUK, which now boasts over 500 members, recently met with Health Secretary Wes Streeting to push for governmental action. The organization also advocates for an NHS screening program to identify individuals at risk from DES exposure.
Breaking the Silence on Men's Health
Maxwell Samuda's decision to speak publicly about his reproductive health challenges represents a significant step in breaking down stigma surrounding men's health issues. "When it comes to men, sometimes it can be a habit of just keeping issues to yourself and overlooking certain things," he acknowledged.
He urged other men to prioritize their health: "The main thing that I would want men to take away from this situation is that when there is something that you spot, get it looked at straight away. There's no reason to hide or to not feel comfortable about what it is that you're experiencing, especially when it comes to things like our reproductive system."
As the DES Justice UK campaign gains momentum, Maxwell and his family hope their story will encourage other affected individuals to come forward and demand accountability for what they describe as one of Britain's most significant medical scandals.
